Ardent Health, Inc. (NYSE:ARDT) Receives $20.30 Consensus Target Price from Analysts

Key Points

• Ardent Health, Inc. has received a consensus rating of "Moderate Buy" from thirteen brokerages, with an average 1-year price target of $20.30.
• Recent performance reviews include a downgrade by Bank of America while Guggenheim and Royal Bank of Canada have issued buy ratings with higher price targets.
• Institutional investors have significantly increased their stakes in Ardent Health, with Nuveen Asset Management growing its share by 220.6% in the fourth quarter.

Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the thirteen research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating, nine have issued a buy rating and two have issued a strong buy rating on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $20.30.

A number of research analysts recently weighed in on the stock. Mizuho decreased their target price on shares of Ardent Health from $19.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Stephens reiterated an "overweight" rating and issued a $21.00 price target on shares of Ardent Health in a research note on Tuesday, May 20th. Guggenheim raised their target price on shares of Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Royal Bank Of Canada restated an "outperform" rating and set a $21.00 target price on shares of Ardent Health in a research note on Thursday, May 15th. Finally, Bank of America cut shares of Ardent Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th.

Ardent Health Trading Down 0.6%

NYSE ARDT traded down $0.06 during trading hours on Monday, hitting $10.62. The company's stock had a trading volume of 98,914 shares, compared to its average volume of 398,544. The stock has a fifty day moving average of $13.21 and a 200 day moving average of $13.64. Ardent Health has a twelve month low of $10.47 and a twelve month high of $20.72. The firm has a market capitalization of $1.52 billion and a P/E ratio of 6.52. The company has a quick ratio of 1.98, a current ratio of 2.12 and a debt-to-equity ratio of 0.70.

Ardent Health (NYSE:ARDT - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.08. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. Ardent Health had a net margin of 3.73% and a return on equity of 16.07%. Equities research analysts forecast that Ardent Health will post 1.23 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Ventas Inc. purchased a new stake in shares of Ardent Health in the fourth quarter valued at about $159,570,000. Vanguard Group Inc. boosted its position in Ardent Health by 368.9% during the first quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company's stock worth $18,296,000 after purchasing an additional 1,046,845 shares during the period. Goldman Sachs Group Inc. boosted its position in Ardent Health by 1,684.9% during the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after purchasing an additional 724,841 shares during the period. Nuveen LLC bought a new position in Ardent Health during the first quarter worth about $6,010,000. Finally, Cubist Systematic Strategies LLC bought a new position in Ardent Health during the first quarter worth about $2,886,000.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.